Achieve Life Sciences, Inc. Restructuring Costs
Achieve Life Sciences, Inc. (ACHV) reported Restructuring Costs of -$267.00 thousand for the 3-month period ending 2014-12-31, per its 10-K filed 2016-03-09.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:RestructuringCosts · last filed 2016-03-09
- Achieve Life Sciences, Inc. restructuring costs for the quarter ending 2014-12-31 was -$267.00K.
- Achieve Life Sciences, Inc. restructuring costs for the quarter ending 2012-12-31 was -$1.66M.
- Achieve Life Sciences, Inc. restructuring costs for the quarter ending 2010-12-31 was $0.00.
- Achieve Life Sciences, Inc. restructuring costs for the quarter ending 2010-09-30 was $4.04M.
- Achieve Life Sciences, Inc. restructuring costs for fiscal 2014 was -$3.52M.
- Achieve Life Sciences, Inc. restructuring costs for fiscal 2012 was -$1.66M.
- Achieve Life Sciences, Inc. restructuring costs for fiscal 2010 was $4.04M, a 2.20% increase from fiscal 2009.
- Achieve Life Sciences, Inc. restructuring costs for fiscal 2009 was $3.95M.
| Period end | Restructuring Costs 3 month | Restructuring Costs 6 month | Restructuring Costs 9 month | Restructuring Costs 12 month |
|---|---|---|---|---|
| 2014-12-31 | -$267.00K 10-K · filed 2016-03-09 | -$3.52M 10-K · filed 2015-03-26 | ||
| 2012-12-31 | -$1.66M 10-K · filed 2014-03-11 | -$1.66M 10-K · filed 2015-03-26 | ||
| 2010-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-07 | $4.04M derived: sum of 2 quarters · filed 2013-03-07 | $4.04M 10-K · filed 2013-03-07 | |
| 2010-09-30 | $4.04M 10-Q · filed 2011-11-03 | $4.04M 10-Q · filed 2011-11-03 | ||
| 2009-12-31 | $3.95M 10-K · filed 2012-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |